Press Releases
Bexion Pharmaceuticals Wins 2015 Tibbetts Award From the Small Business Administration
FOR IMMEDIATE RELEASE Margaret van Gilse 859-757-1652 [email protected] COVINGTON, KY, June 1, 2015 -- Bexion Pharmaceuticals LLC announced that the Small Business Administration (SBA) has awarded the Company the prestigious Tibbetts Award, recognizing Bexion as a “Model of Excellence” for the Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Awarded to less than two dozen companies nationwide in [...]
Bexion Pharmaceuticals Receives Orphan Drug Designation for Saposin C, the Active Ingredient in BXQ-350 for Glioblastoma Multiforme from FDA
FOR IMMEDIATE RELEASE Margaret van Gilse 859-757-1652 [email protected] COVINGTON, KY, Feb. 16, 2015 -- Bexion Pharmaceuticals LLC announced today that the U.S. Food and Drug Administration (FDA) has granted the company Orphan Drug designation for Saposin C, active ingredient in its proprietary drug BXQ-350 for the potential treatment of glioblastoma multiforme. The FDA’s Office of Orphan Drug Products Development reviews applications for Orphan [...]
